Document is current
Any future updates will be listed below
-
Authors
Wickwire, Emerson M.
Collen, Jacob
Capaldi, Vincent F. II
Zhao, Zhiwei
Williams, Scott G.
Thomas, Connie L.
Assefa, Samson Z.
Albrecht, Jennifer S.
Chen, Shuo
-
Funding
Funding for this research was provided by:
DoD (W81XWH1990006 via the Medical Technology Enterprise Consortium)
DoD (W81XWH1990006 via the Medical Technology Enterprise Consortium)
DoD (W81XWH1990006 via the Medical Technology Enterprise Consortium)
DoD (W81XWH1990006 via the Medical Technology Enterprise Consortium)
DoD (W81XWH1990006 via the Medical Technology Enterprise Consortium)
- License Information
-
More Information
Article History
Received: 3 April 2024
Accepted: 7 August 2024
First Online: 1 October 2024
Competing interests
: EMW’s institution has received research funding from the AASM Foundation, Department of Defense, Merck, NIH/NIA, ResMed, the ResMed Foundation, and the Sleep Research Society Foundation. EMW has served as a scientific consultant to Axsome Therapeutics, DayZz, Eisai, EnsoData, Idorsia, Merck, Nox Health, Primasun, Purdue, and ResMed and is an equity shareholder in WellTap.
